Romaco at INTERPHEX 2023 – Broad Portfolio for Lab Applications

Romaco’s technologies and services for laboratory applications will be at the center of the one stop solutions provider’s trade fair exhibit. The multipurpose VENTILUS® Lab fluid bed processor from Romaco Innojet and the KTP 1X R&D tablet press from Romaco Kilian will be on display at the upcoming even

Romaco will take advantage of INTERPHEX to show technologies and services for laboratory applications. The one stop solutions provider’s processing portfolio includes high shear mixers, fluid bed processors, tablet presses and tablet coaters for laboratory scale production. Sustainable system design is a key development priority with all Romaco machines – for example, through targeted energy savings in processing or reduced raw material consumption in the manufacture and processing of pharmaceutical powders, granulates and tablets. These measures not only improve the carbon footprint; they also go hand in hand with lower production costs.

Romaco additionally has six laboratories for granulation, tableting and film coating as well as filling and packing of pharmaceutical solids and liquids. These knowledge centers serve as the first port of call for expert advice, product analyses, process optimization and machine training. Parallel to this, lab specialists from Innojet, Kilian and Tecpharm provide scale-up and product development support to users in the pharmaceutical industry.

VENTILUS® Lab fluid bed processor from Romaco Innojet – a multipurpose all-rounder with significant energy saving potential

Designed for laboratory-scale applications, the VENTILUS® Lab fluid bed processor from Romaco Innojet is used for granulating, drying and coating particle sizes from 10 μm to 2 mm. This multipurpose lab unit produces batches from 0.7 to 7.0 liters in size. Due to the enhanced processing efficiency inside the cylindrical product container, the VENTILUS® Lab allows up to 25 percent shorter batch processing times and hence much lower power consumption. The process air is introduced through the ORBITER® booster plate, which ensures homogeneous flow conditions and extremely gentle intermixing of the materials. In combination with the ROTOJET®, the central bottom spray nozzle, the ORBITER® booster forms a unique functional unit enabling simple scale-up. Thanks to the innovative fluid bed components invented by Dr. h. c. Herbert Hüttlin, the product movement inside the process container can be accurately controlled. The spray liquid is consequently applied very precisely, so that formulations achieving the modified release profile are possible using 10 to 15 percent less material. The targeted reduction in spray liquid and power consumption means the VENTILUS® Lab also results in substantially fewer carbon dioxide emissions from fluid bed processes. Furthermore, the rotating SEPAJET® filter system minimizes product loss by preventing any particles retained by the filter from being discharged from the process.

KTP 1X R&D tablet press 2.0 from Romaco Kilian – access to research data worldwide at any time – Industry 4.0 ready

The KTP 1X is the newest generation of Romaco Kilian’s R&D tablet presses for laboratory use. This single-stroke press was designed as an all-in-one instrument for research and development activities and is suitable for pressing mono-layer, bi-layer and triple-layer tablets as well as tab-in-tab formats. It achieves compression forces of up to 80 kN depending on the model and a maximum output of 1800 tablets per hour. This versatile R&D press enables the various tableting parameters, such as compression force or the possible tableting speed, to be automatically determined. The smart measurement system evaluates huge amounts of data in next to no time for this purpose. The KTP 1X is moreover capable of simulating any standard rotary press, making it much easier to conduct scale-up trials. In addition to the production of clinical samples, the technology allows detailed troubleshooting and hence supports process optimization. Thanks to the machine’s extremely good rigidity, the punch position in particular can be measured more precisely now. This high measuring accuracy goes hand in hand with extremely low product consumption – so that the KTP 1X is not only very accurate but also cost-efficient and sustainable. Only a few test series are required to obtain meaningful results, because compression studies are highly automated. With its very small compaction area, the tablet press has a small footprint and is quick and easy to clean – for even bigger time and energy savings. What’s more, the machine ships with a data module that gives users access to raw measurement data worldwide at any time, even when the machine is not in operation.

On show at INTERPHEX in New York (USA) from April 25 to 27, 2023 (Javits Center, Stand 3309).

SourceRomaco

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version